Form 4/A for BEAM Beam Therapeutics Inc.
Accepted 2022-02-02 00:00:00 ET · period of report 2022-01-31 · accession 0000899243-22-004197 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMAI | 2022-02-02 | 2022-01-31 | BEAM | Evans John M. | CEO, Dir | S - Sale+OE | $66.85 | -20.0K | 181.1K | -10% | -$1.34M |
| DA | 2022-02-02 | 2022-01-31 | BEAM | Evans John M. | CEO, Dir | M - OptEx | $1.03 | +100.0K | 1.04M | +11% | +$103.0K |
| DMA | 2022-02-02 | 2022-01-31 | BEAM | Evans John M. | CEO, Dir | S - Sale+OE | $66.83 | -30.0K | 968.0K | -3% | -$2.00M |
| DA | 2022-02-02 | 2021-11-16 | BEAM | Evans John M. | CEO, Dir | G - Gift | $0.00 | -12.0K | 968.8K | -1% | $0 |
| DA | 2022-02-02 | 2022-01-31 | BEAM | Evans John M. | CEO, Dir | A - Grant | $0.00 | +112.5K | 112.5K | New | $0 |
| DA | 2022-02-02 | 2022-01-31 | BEAM | Evans John M. | CEO, Dir | M - OptEx | $0.00 | -100.0K | 284.3K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-31 | S | D | 300 | $63.45 | 182,700 | I | — | — | (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.26 to $63.58, inclusive. |
| 2 | Common | Common Stock | 2022-01-31 | M | A | 100,000 | $1.03 | 1,038,825 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-31 | S | D | 3,978 | $68.15 | 938,825 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.00 to $68.60, inclusive. |
| 4 | Common | Common Stock | 2022-01-31 | S | D | 13,535 | $67.44 | 942,803 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.00 to $67.99, inclusive. |
| 5 | Common | Common Stock | 2022-01-31 | S | D | 6,337 | $66.55 | 956,338 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.09 to $66.94, inclusive. |
| 6 | Common | Common Stock | 2022-01-31 | S | D | 3,177 | $65.49 | 962,675 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.20 to $65.99, inclusive. |
| 7 | Common | Common Stock | 2022-01-31 | S | D | 2,172 | $64.47 | 965,852 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.21 to $64.50, inclusive. |
| 8 | Common | Common Stock | 2022-01-31 | S | D | 801 | $63.79 | 968,024 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.60 to $63.96, inclusive. |
| 9 | Common | Common Stock | 2021-11-16 | G | D | 12,000 | $0.00 | 968,825 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | |
| 10 | Common | Common Stock | 2022-01-31 | S | D | 2,672 | $68.16 | 163,000 | I | — | — | (F14) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.00 to $68.60, inclusive. |
| 11 | Common | Common Stock | 2022-01-31 | S | D | 9,408 | $67.43 | 165,672 | I | — | — | (F13) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.00 to $67.99, inclusive. |
| 12 | Common | Common Stock | 2022-01-31 | S | D | 4,105 | $66.48 | 175,080 | I | — | — | (F12) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.00 to $66.94, inclusive. |
| 13 | Common | Common Stock | 2022-01-31 | S | D | 1,900 | $65.55 | 179,185 | I | — | — | (F11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.20 to $65.99, inclusive. |
| 14 | Common | Common Stock | 2022-01-31 | S | D | 1,615 | $64.46 | 181,085 | I | — | — | (F10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.17 to $64.50, inclusive. |
| 15 | Derivative | Stock Option (Right to Buy) | 2022-01-31 | A | A | 112,500 | $0.00 | 112,500 | D | $69.21 · — to 2032-01-31 | 112,500 Common Stock | (F16) The option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the reporting person's continued service with BEAM through each vesting date. |
| 16 | Derivative | Stock Option (Right to Buy) | 2022-01-31 | M | D | 100,000 | $0.00 | 284,345 | D | $1.03 · — to 2028-07-13 | 100,000 Common Stock | (F15) The option vests as to 25% on the first anniversary of the of the vesting commencement date, January 8, 2018, and at a rate of 2.78% each month thereafter until the option is fully vested. |